These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970 [TBL] [Abstract][Full Text] [Related]
5. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways. Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306 [TBL] [Abstract][Full Text] [Related]
6. Folliculotropic mycosis fungoides in a pediatric patient with response to psoralen-ultraviolet A phototherapy. Boix-Vilanova J; Corral-Magaña O; Martin-Santiago A; Escalas J Photodermatol Photoimmunol Photomed; 2019 Jan; 35(1):54-56. PubMed ID: 30007081 [TBL] [Abstract][Full Text] [Related]
7. Childhood mycosis fungoides: experience of 28 patients and response to phototherapy. Laws PM; Shear NH; Pope E Pediatr Dermatol; 2014; 31(4):459-64. PubMed ID: 24916067 [TBL] [Abstract][Full Text] [Related]
8. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study. Ahmad K; Rogers S; McNicholas PD; Collins P Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648 [TBL] [Abstract][Full Text] [Related]
9. Phototherapy for mycosis fungoides. Dogra S; Mahajan R Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327 [TBL] [Abstract][Full Text] [Related]
10. Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy. Goteri G; Rupoli S; Campanati A; Zizzi A; Picardi P; Cardelli M; Giantomassi F; Canafoglia L; Marchegiani F; Mozzicafreddo G; Brandozzi G; Stramazzotti D; Ganzetti G; Lisa R; Simonetti O; Offidani A; Federici I; Filosa G; Leoni P Br J Dermatol; 2012 May; 166(5):948-52. PubMed ID: 22233400 [TBL] [Abstract][Full Text] [Related]
11. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium. Olsen EA; Hodak E; Anderson T; Carter JB; Henderson M; Cooper K; Lim HW J Am Acad Dermatol; 2016 Jan; 74(1):27-58. PubMed ID: 26547257 [TBL] [Abstract][Full Text] [Related]
12. The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma. Spaccarelli N; Rook AH Dermatol Clin; 2015 Oct; 33(4):731-45. PubMed ID: 26433845 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056). Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Early Folliculotropic Mycosis Fungoides with Special Focus on Psoralen plus Ultraviolet A. Amitay-Laish I; Prag-Naveh H; Dalal A; Pavlovsky L; Feinmesser M; Hodak E Acta Derm Venereol; 2018 Nov; 98(10):951-955. PubMed ID: 30085321 [TBL] [Abstract][Full Text] [Related]
15. Local radiation and phototherapy are the most cost-effective treatments for stage IA mycosis fungoides: A comparative decision analysis model in the United States. Xia FD; Ferket BS; Huang V; Stern RS; Wu PA J Am Acad Dermatol; 2019 Feb; 80(2):485-492.e4. PubMed ID: 30081119 [TBL] [Abstract][Full Text] [Related]
16. Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto. Almohideb M; Walsh S; Walsh S; Shear N; Alhusayen R Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):604-612. PubMed ID: 28711574 [TBL] [Abstract][Full Text] [Related]
17. Mycosis fungoides with follicular mucinosis displaying aggressive tumor-stage transformation : successful treatment using radiation therapy plus oral bexarotene combination therapy. Apisarnthanarax N; Ha CS; Duvic M Am J Clin Dermatol; 2003; 4(6):429-33. PubMed ID: 12762834 [TBL] [Abstract][Full Text] [Related]
18. Phototherapy as a treatment of early-stage mycosis fungoides and predictive factors for disease recurrence: A 17-year retrospective study. Rattanakaemakorn P; Ploydaeng M; Udompanich S; Thadanipon K; Rutnin S; Rajatanavin N Indian J Dermatol Venereol Leprol; 2021; 87(5):645-650. PubMed ID: 33871205 [TBL] [Abstract][Full Text] [Related]
19. The treatment of mycosis fungoides. Mestel DS; Beyer M; Steinhoff M; Sterry W; Assaf C G Ital Dermatol Venereol; 2008 Dec; 143(6):395-408. PubMed ID: 19169212 [TBL] [Abstract][Full Text] [Related]
20. Maintenance phase in psoralen-ultraviolet A phototherapy of early-stage mycosis fungoides. A critically appraised topic. Grandi V; Delfino C; Pileri A; Pimpinelli N Br J Dermatol; 2017 Aug; 177(2):406-410. PubMed ID: 28078669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]